Valuation (74%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 18.89 | 30.29 |
| PEG Ratio (TTM) | 1.14 | -0.29 |
| P/S Ratio (TTM) | 0.80 | 3.55 |
| P/B Ratio (TTM) | 1.10 | 31.78 |
| P/FCF Ratio (TTM) | 22.13 | 24.81 |
| Price to 5YR AVG Earnings Ratio | 8.36 | 26.61 |
| Price to 5YR AVG FCF Ratio | 1,905.92 | 24.43 |
Profitability (18%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.25% | 10.83% |
| ROE (TTM) | 5.69% | 118.76% |
| Net Profit Margin (TTM) | 4.21% | 13.03% |
| ROIC 5YR AVG | 1.73% | 26.41% |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 144.93% | -182.67% | 378.05% |
| Revenue | 1.25% | -5.21% | -4.18% |
| Net Income | 115.50% | -178.41% | 362.26% |
| Cash Flow | 555.02% | 8,723.87% | 5,129.95% |
Health (74%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.30 | 0.91 |
| Quick Ratio (TTM) | 1.62 | 0.64 |
| D/E Ratio (TTM) | 0.26 | 3.87 |
| Interest Coverage (TTM) | 2.92 | 15.03 |
| Piotroski F-Score | 8 | 8 |
| Altman Z-Score | 2.89 | 5.30 |
| LTL to 5YR AVG FCF | 514.84 | 4.38 |
| Shares Outstanding Growth 5YR AVG | -9.45% | -0.20% |